PL359246A1 - Nowy specyficzny mechanizm hamowania adhezji płytek krwi do kolagenu - Google Patents

Nowy specyficzny mechanizm hamowania adhezji płytek krwi do kolagenu

Info

Publication number
PL359246A1
PL359246A1 PL01359246A PL35924601A PL359246A1 PL 359246 A1 PL359246 A1 PL 359246A1 PL 01359246 A PL01359246 A PL 01359246A PL 35924601 A PL35924601 A PL 35924601A PL 359246 A1 PL359246 A1 PL 359246A1
Authority
PL
Poland
Prior art keywords
platelet adhesion
collagen
saratin
specific mechanism
new specific
Prior art date
Application number
PL01359246A
Other languages
English (en)
Other versions
PL203469B1 (pl
Inventor
Christopher Barnes
Matthias Frech
Uwe Hofmann
Johannes Gleitz
Wolfgang Strittmatter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL359246A1 publication Critical patent/PL359246A1/pl
Publication of PL203469B1 publication Critical patent/PL203469B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
PL359246A 2000-08-25 2001-08-23 Zastosowanie polipeptydowej Saratyny do wytwarzania leku PL203469B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00118542 2000-08-25
EPEP00118542.0 2000-08-25

Publications (2)

Publication Number Publication Date
PL359246A1 true PL359246A1 (pl) 2004-08-23
PL203469B1 PL203469B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
ZA200302296B (en) 2004-06-30
ATE285246T1 (de) 2005-01-15
RU2302880C2 (ru) 2007-07-20
AR030492A1 (es) 2003-08-20
SK287829B6 (sk) 2011-11-04
PT1311284E (pt) 2005-05-31
SI1311284T1 (pl) 2005-08-31
NO20030841D0 (no) 2003-02-24
SK3132003A3 (en) 2003-08-05
ES2234896T3 (es) 2005-07-01
DK1311284T3 (da) 2005-04-18
DE60107962D1 (de) 2005-01-27
ECSP034485A (es) 2003-03-31
DE60107962T2 (de) 2005-12-15
US20030190342A1 (en) 2003-10-09
CN1449291A (zh) 2003-10-15
AU2001295506B2 (en) 2007-02-15
HK1059736A1 (en) 2004-07-16
HU229367B1 (en) 2013-11-28
JP4988131B2 (ja) 2012-08-01
WO2002015919A3 (en) 2002-05-30
US7459438B2 (en) 2008-12-02
BR0113478A (pt) 2003-07-15
JP2004506690A (ja) 2004-03-04
EP1311284A2 (en) 2003-05-21
CA2419385C (en) 2011-05-10
CZ302353B6 (cs) 2011-03-30
CA2419385A1 (en) 2002-02-28
NO20030841L (no) 2003-02-24
NO331326B1 (no) 2011-11-28
WO2002015919A2 (en) 2002-02-28
CN1224421C (zh) 2005-10-26
US20050143305A1 (en) 2005-06-30
KR100794277B1 (ko) 2008-01-11
US6881722B2 (en) 2005-04-19
MY128992A (en) 2007-03-30
CZ2003720A3 (cs) 2003-06-18
HUP0303747A3 (en) 2006-01-30
MXPA03001604A (es) 2003-06-04
HUP0303747A2 (hu) 2004-03-01
EP1311284B1 (en) 2004-12-22
KR20030034141A (ko) 2003-05-01
AU9550601A (en) 2002-03-04
UA77402C2 (en) 2006-12-15

Similar Documents

Publication Publication Date Title
ZA979822B (en) Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent.
WO2002089743A3 (en) Use of compositions for treating rosacea
WO2003009778A3 (en) Methods and devices for delivery of therapeutic capable agents with variable release profile
AU2002365875A1 (en) Stent designed for the delivery of therapeautic substance or other agents
WO2003042246A3 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
YU63699A (sh) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
ATE397445T1 (de) Synergistische kombinationen enthaltend einen renininhibitor für kardiovaskulären erkrankungen
YU82602A (sh) Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze
MXPA03001604A (es) Nuevo mecanismo especifico para inhibir la adhesion de plaquetas al colageno.
AU2002330850A1 (en) Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents
IS4782A (is) Stýring græðsluferlis
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
EP0870502A3 (en) Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
PT1187612E (pt) Utilizacao do riluzole para o tratamento da esclerose multipla
IL130500A (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
WO2002022074A3 (fr) Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
MY140504A (en) Statin-mmp inhibitor combinations
GEP20074101B (en) Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
AU2001287560A1 (en) Agent for inhibiting adhesion of the pathogenic flora of the skin
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis